Clinical Trial Update: Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Heptral in subjects with liver disease due to alcohol consumption has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholestasis Associated with Alcoholic Liver Disease

Drugs mentioned

• Heptral (S-adenosyl-L-methionine)

Snippet

Sponsor: Abbott | Conditions: Intrahepatic Cholestasis Associated With Alcoholic Liver Disease | Phase 3 | Status: COMPLETED